ACRS - Aclaris Therapeutics Stock Trading

Aclaris Therapeutics Inc.(NASDAQ: ACRS) stock trading, description, contact, officers and directors.

About Aclaris Therapeutics Inc.

Aclaris Therapeutics, Inc. is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology

Stock Information

Aclaris Therapeutics Inc. Company Name:

ACRS Stock Symbol:

NASDAQ Market:

Aclaris Therapeutics Inc. Website:

ACRS - Aclaris Therapeutics Stock Trading

ACRS ACRS Quote ACRS Short ACRS News ACRS Articles ACRS Message Board

Get ACRS Alerts

News, Short Squeeze, Breakout and More Instantly...

ACRS - Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference

WAYNE, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Wednes...
ACRS - Aclaris Therapeutics EPS beats by $0.01, beats on revenue

Aclaris Therapeutics (NASDAQ: ACRS ): Q1 GAAP EPS of -$0.37 beats by $0.01 . More news on: Aclaris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
ACRS - Aclaris Therapeutics Reports First Quarter 2020 Financial Results and Provides R&D and Business Highlights

Projected Cash Runway into the First Quarter of 2022 Borrowed $11 Million from Term Loan Facility WAYNE, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today an...